An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer

Clinical trial NCT06560112 · RECRUITING

Trial details

NCT number: NCT06560112
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer

Start date: 2024-11-12
Primary completion: 2026-05-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.